Clinical Trials, Retina Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE 2) by ClinicalTrialsFeed • 2010/10/19 • 0 Comments Status: Recruiting, Condition Summary: Ischemia; Retinal Vein Occlusion; Pathologic Processes; Retinal Diseases; Eye Diseases Full Story →